Cellular Therapeutics for Heart Failure: Focus on Mesenchymal Stem Cells
Resulting from a various etiologies, the most notable remains ischemia; heart failure (HF) manifests as the common end pathway of many cardiovascular processes and remains among the top causes for hospitalization and a major cause of morbidity and mortality worldwide. Current pharmacologic treatment...
Main Authors: | Amitabh C. Pandey, Jordan J. Lancaster, David T. Harris, Steven Goldman, Elizabeth Juneman |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2017/9640108 |
Similar Items
-
Stem Cell Therapeutics in Heart Failure
by: André Miguel Airosa Pereira Fernandes Pardal
Published: (2019) -
Development and Testing of a Tissue Engineered Cardiac Construct for Treatment of Chronic Heart Failure
by: Lancaster, Jordan, et al.
Published: (2016) -
Mesenchymal Stem Cells as Cellular Vehicles Encapsulate Therapeutic Retroviruses Against Gliomas
by: Yu-Hsuan Yang, et al.
Published: (2013) -
The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure
by: Yantao He, et al.
Published: (2018-10-01) -
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications
by: Nicola Stefano Fracchiolla, et al.
Published: (2017-01-01)